While complement activation is a noted feature for clinical manifestations of APS, such activation likely occurs locally that may not result in systemic and parallel decline of plasma protein levels for C4 and C3, a phenomenon analogous to what we observed in many patients with juvenile dermatomyositis (82). The gene discussed is C4A; the disease is juvenile dermatomyositis.